Among the first 83 patients treated with percutaneous transluminal coronary angioplasty (PTCA) at our institution, typical variant angina was recognized beforehand in five cases and was discovered within 4 months of PTCA in six others. All patients had a 65-95% proximal left anterior descending coronary artery stenosis and only one had a coronary lesion >50% in other coronary arteries. Before PTCA, all patients were premedicated with calcium-antagonist drugs. Thirteen of 15 PTCAs, including three of four repeat PTCAs, were technically successful. However, variant angina recurred after successful PTCA in three of the five patients in whom it was documented beforehand and in an additional two of two patients with variant angina before a successful repeat PTCA. Overall, among the nine patients with variant angina after successful PTCA, five had restenosis at the site of PTCA and two others developed severe lesions adjacent to the site of PTCA within 4 months of the procedure. The three patients without restenosis have been treated with calcium-antagonist drugs from soon after PTCA and have remained angina-free.
A SPECTRUM of coronary arteriographic findings are seen in patients with variant angina, ranging from normal arteries to severe multivessel disease.' Variant angina can usually be controlled with calcium-antagonist drugs.4 I Although patients with organic lesions often do well after bypass surgery, 6 7 the results are poorer than in other subsets of coronary disease,8 9 and variant angina may occur after surgery in spite of patent grafts.'°V ariant angina is caused by coronary spasm, but the cause of spontaneous coronary spasm is unclear. However, coronary spasm in variant angina is intimately associated with organic lesions if they are present; thus, of 69 adequately documented cases with organic lesions collected by MacAlpin,' spasm occurred at the stenosis in 62. If the organic stenoses were not present, would spasm still have occurred? MacAlpin"' reasoned that coronary vasomotion within the normal physiologic range could theoretically obstruct a pliable vessel at the site of a severe organic stenosis. Under these conditions, eliminating the organic stenosis would theoretically prevent intermittent vasoconstrictive occlusion of the artery. These considerations suggest that reduction of the severity of the organic stenosis in patients with variant angina might relieve symptoms. Therefore, we considered percutaneous transluminal coronary angioplasty (PTCA) as a treatment for some patients with variant angina.
Among the first 83 patients treated with PTCA at our institution, typical variant angina was recognized before the procedure in five cases and was discovered within 4 months after PTCA in six others. In this report we describe the clinical evolution of these patients and discuss the implications of our findings.
Methods

Patients
For this study, the diagnosis of variant angina was made in patients who met the following criteria: burning or squeezing retrosternal chest pain at rest; sublingual nitroglycerin relieving the pain in less than 5 minutes; ST elevation of at least 0.2 mV not present on the baseline ECG but documented during pain and disappearing with relief of pain; and no subsequent evidence of myocardial necrosis. Variant angina was also diagnosed when these events were provoked by ergonovine.
Between [OBER 1982 previously described techniques, 4 except if the patients were thought to have unstable angina. Efforts were made to record a 12-lead ECG during spontaneous episodes of angina at rest. In patients with suspected or documented variant angina, an ergonovine test was performed, usually in the coronary care unit using a protocol described in detail elsewhere 15 but occasionally during coronary arteriography.
Patients not known to have variant angina were treated with diltiazem, 90 or 120 mg, on the evening before and the morning of PTCA; patients with known variant angina received 90 or 120 mg of diltiazem, 20-40 mg of nifedipine and 60 mg of isosorbide dinitrate orally 2 hours before PTCA. All patients were treated with sulfinpyrazone, 200 mg four times daily. beginning 3 days before and continuing for 6 months after PTCA.
Coronary arteriography was performed by a percutaneous transfemoral approach using preformed polyethylene catheters;'6 craniocaudal and caudocranial, sagittally angulated views of the left coronary artery were routinely filmed. All organic lesions were refilmed in multiple views after nitroglycerin administration. The PTCA technique we use is similar to that of Griintzig et al. 12 The pressure gradient across the stenosis was measured before and after each balloon inflation except in patients 2 and 11. in whom a Simpson catheter17 was used. A USCI inflation device was used for balloon inflation; the inflation medium was contrast material warmed and diluted to 30% of the usual concentration. The number of balloon inflations varied depending on the residual gradient across the stenosis and the appearance of the lesion during control angiography filmed in at least three views. The first inflation was to 4 atmospheres for 5-10 seconds. With successive inflations the pressure was increased by 1atmosphere increments to 5 or 6 atmospheres without increasing duration. If further inflations were required, the highest pressure was repeated and the duration was increased incrementally to a maximum of 25 seconds. During PTCA, nitroglycerin was infused intravenously at 10-30 ,g/min in all cases. Boluses of intracoronary nitroglycerin were added if waxing and waning of the distal coronary artery pressure was noted or if partial coronary spasm was suspected because of the angiographic appearance of the artery.
For 24 hours after PTCA, all patients underwent continuous electrocardiographic monitoring. Graded treadmill exercise testing with 15 ECG leads was repeated at 1, 3 and 6 months after PTCA, including thallium-201 studies at the 1and 6-month tests. Coronary arteriography was performed 6 months after PTCA in all cases. As described below, coronary arteriography was repeated sooner in some patients with suspected restenosis or variant angina. The treatment of variant angina after PTCA varied from patient to patient, influenced by the results of treatment in the earlier cases. As previously noted, all patients received calcium antagonists and long-acting nitrates before PTCA. Before the initial PTCA, no patient had been treated with a calcium antagonist for longer than 1
week. Calcium antagonists and nitrates were not given after the first PTCA, except to patient 3? but were restarted when variant angina recurred. Patients who underwent a second PTCA were treated with calcium antagonists for at least 6 months thereafter, irrespective of their clinical status.
All angiographic documents were interpreted independently by an experienced cardiovascular radiologist. Coronary artery stenoses are defined according to the criteria of the Coronary Artery Surgery Study'6: the estimated percentage of obstruction is derived from the angiographic view showing the greatest reduction in diameter for the vessel in question. All measurements were made after the administration of nitroglycerin and all comparisons between pre-PTCA and post-PTCA films were made using the same view. nitroglycerin. An exercise test was stopped at 6 minutes at a heart rate of 102 beats/min because of angina and ST elevation; the corresponding thallium scan revealed a large anterior zone of hypoperfusion that was absent from the resting scan. An ergonovine test was positive at a dose of 0.025 mg, with ST elevation in leads I, aVL and V, to V4. Treatment with nifedipine. diltiazem and long-acting nitrates eliminated the spontaneous attacks of variant angina, and an ergonovine test during this treatment was negative to the maximal dose of 0.4 mg. Because of the patient's reluctance to continue medical treatment, PTCA was performed, reducing the LAD stenosis from 70% to 35% (fig. iB) and the gradient from 38 to 13 mm Hg. Coronary spasm did not occur during the procedure. Three days later, all medication was discontinued and angina did not recur. An ergonovine test was negative to the maximal dose.
The patient was discharged without cardiac medication and remained asymptomatic for 2 months. At 2 months, coronary arteriography was repeated and showed no change; however, an ergonovine test done during angiography induced angina, ST ued after the second PTCA, and the patient had neither rest nor effort angina. Coronary arteriography 6 months after the second PTCA showed a partial restenosis graded at 50%; ergonovine administration during arteriography induced focal coronary spasmn less intense than that after the first PTCA.
Patienit 6
A 36-year-old engineer was referred for PTCA because of effort angina of 3 months' duration in spite of medical treatment. Two months previously he had been hospitalized because of rest angina. An 85% proximal isolated LAD stenosis ( fig. 2A ) with otherwise normal arteries and a normal left ventriculogram were found. Rest angina occurred infrequently and an ECG was never recorded during an episode. An 2F ). Nine months later, infrequent episodes of rest anginaoccurred despite treatment with diltiazem, 120 mg three times daily.
Results Table 1 is a summary of the clinical and angiographic data before and after PTCA for the 11 patients in this study. Table 2 is a summary of the clinical outcomes. Before PTCA All 11 study patients-had rest angina; 10 of the I1 also had effort angina before PTCA. The mean duration of rest angina was 3.9 months (range 1-8 months) and of effort angina was 3 months (range 1-6 months). The clinical syndrome of variant angina was documented before-PTCA in five patients (nos. 1-5). In three of these five, transient ST elevation was present on an ECG-recorded during rest angina. In the other two, ergonovine administration induced angina and ST elevation.
Only one of the six patients in whom variant angina was diagnosed after PTCA (patient 11) had an ECG recorded during-an episode of rest angina and only one (patient 10) had an ergonovine test beforehand; the procedure was normal in both patients.
Each patient had a proximal LAD stenosis graded at 65-95%. No patient had an additional coronary lesion >50% elsewhere except-for patient 9, who had a 60% distal right-c-oronary artery stenosis. ST elevation was localized to the anterior ECG leads in all 11 cases, in the territory of the LAD stenosis. Each of the four patients (nos. 1, 6, 7 and 9) who had spontaneous or provoked spasm during arteriography had focal spasm at the site of the LAD lesion.
After PTCA Patients 1-5 had variant angina documented before PTCA; patients 1-4 had a successful PTCA. In patient 5, the lesion could not be crossed. Variant angina recurred after PTCA -in three of the four successful cases (patients 1, 2 and 4). Restenosis was documented in two (patients 1 and 4); a second PTCA was successful in one (patient 1); the other (patient 4) received medical therapy. In the third patient (no. 2), variant angina recurred during the week after PTCA; treatment with calcium antagonists eliminated all symptoms, and repeat coronary arteriography at 6 months demonstrated no restenosis.
PTCA was also successful in patients 6-11, in whom variant angina was-not diagnosed before PTCA.
Variant angina was demonstrated after PTCA by an ECG recorded during rest angina in three, patients 6, 9 and 11, and by ST elevation during an ergonovine test in patients 7, 8 and 10. In spite of the initially successful result in these six patients, three (nos. 6, 10 and 11) developed restenosis and two others (nos. 7 and 9) developed severe lesions adjacent to the site of PTCA within 4 months of the procedure. In patient 8, variant angina was detected soon after PTCA, treatment with calcium antagonist drugs eliminated all symptoms and repeat arteriography at 6 months demonstrated no restenosis or new lesions.
Overall, coronary artery spasm did not occur during 14 of the 15 PTCAs in the 11 study patients, including repeat PTCAs for restenosis in patients 1, 6 and 10. Patient 9 was the only patient who developed complications during PTCA. His first PTCA was successful, reducing the LAD stenosis from 65% to 25% and the gradient from 30 to 15 mm Hg, but 3/2 months later, rest angina recurred, with ST elevation in leads aVL and V, to V3. Arteriography revealed no change in the LAD at the site of PTCA, but a new 75% stenosis had developed in the mid-LAD since the previous arteriogram. PTCA reduced this lesion to 40%, but during the procedure coronary spasm developed that completely occluded the LAD at the site of the initial PTCA and required intracoronary nitroglycerin for relief. Six hours later the patient had an acute anterior transmural infarction.
Patients 1, 6 and 10 had a technically successful repeat PTCA, but variant angina persisted after this procedure in patients 6 and 10 and patient 1 continued to have a positive response to ergonovine, but remained angina-free on calcium-antagonist drugs.
Discussion This study indicates that PTCA is technically feasible in patients with variant angina and a coexisting organic coronary stenosis. All of our patients were premedicated with at least one calcium-antagonist drug, and during PTCA, all received an infusion of i.v. nitroglycerin. Coronary spasm occurred in only one patient during PTCA, and although this patient subsequently developed a myocardial infarction, the incidence of complications in these patients does not appear to be much higher than that in other patients who undergo PTCA'2 20 or in patients with active variant angina.3 21 PTCA has not been recommended for patients with coronary spasm. Spasm during PTCA has, in a few cases, been associated with infarction12 or has been an indication for urgent bypass surgery.20 Coronary spasm during PTCA is a distinct clinical entity, analogous to catheter-induced spasm during coronary arteriography, but unrelated to the spontaneous or ergonovine-induced spasm that occurs in variant angina. In each of the patients in this study, variant angina was documented either before or 3 days to 4 months after PTCA, and was thus independent of PTCA-related coronary spasm. The possibility that PTCA caused vessel injury and subsequent spasm seems unlikely because an asymptomatic interval of at least 4 weeks followed PTCA in seven of the nine patients with variant angina after PTCA.
The syndrome of variant angina is characterized by frequent spontaneous exacerbations and remissions,22 23 making the effect of any treatment difficult to evaluate; however, our results indicate that PTCA alone is inadequate treatment for variant angina. Variant angina recurred after a successful first PTCA in three of four cases and after a successful repeat PTCA TABLF in two ot two additional patients. The data from this study are insufficient to determine whether the combination of PTCA with appropriate medical treatment improves the prognosis of selected patients with variant angina compared with medical treatment alone.
The incidence of restenosis after successful PTCA has not been accurately defined, but is probably 15-20% in the first 6 months.12 17 19 20 In contrast, seven of the 10 successfully dilated patients in this study developed either restenosis or a new severe lesion adjacent to the site of PTCA within 6 months.
These results raise the possibility that multiple episodes of focal coronary spasm could have caused restenosis in these patients. The fact that the three patients who did not develop restenosis had been treated with calcium antagonists soon after PTCA and had remained angina-free adds further support to this hypothesis. Few data are available defining the rate of progression of coronary obstructive disease in patients with variant angina compared with other coronary patients. Recently, Marzilli et al. 4 speculated that a cause of atherosclerotic lesions in all patients with ischemic heart disease might be coronary spasm. The evidence supporting this contention is scanty. Nevertheless, it is attractive to postulate that the cause of restenosis in PTCA patients with variant angina could be repetitive coronary spasm.
A high incidence of variant angina, often undiagnosed, is present in patients referred to our institution for PTCA. The selection criteria for PTCA, severe angina in spite of medical treatment. a proximal, isolated, noncalcified stenosis of a single vessel without We conclude that platelet TxA2 is probably not responsible for the initiation of coronary vasospasm. THROMBOXANE A, (TxA2), a derivative of arachidonic acid, is mainly produced by platelets and actively released during platelet release reaction. ' TxA, is a powerful constrictor of vascular smooth muscle2 and may be a cause of coronary vasospasm.3-Increased levels of thromboxane B2 (TxB,), the stable nonenzymatic metabolite of TxA2, have been found in the peripheral blood of patients with variant angina,3 a widely recognized hallmark of vasospastic ischemia.7-' Whether high levels of TxA, play a primary role in precipitating coronary vasospasm or merely represent an epiphenomenon of transient myocardial ischemia, however, is still uncertain. The present study was aimed at assessing the effects of a single, low, i.v. dose of aspirin, which blocks the release of platelet TxA, 10 on the number, severity and duration of episodes of transient acute ischemia caused by coronary vasospasm. sodes of angina at rest. Transient ST-segment elevation was documented in six patients by serial 12-lead ECGs recorded in the coronary care unit during several anginal episodes; ST-segment depression was consistently observed in one patient (BU), in whom spasm was demonstrated angiographically. Every patient underwent continuous ECG monitoring/recording in the coronary care unit to assess objectively the frequency of ischemic episodes even if asymptomatic. The ECG lead showing the most evident ST-segment changes during the episode was selected for this purpose. All seven patients had 10 or more episodes of transient myocardial ischemia per day documented by typical transient ischemic changes.
Coronary arteriography, performed in all patients by the Judkins technique, showed variable degrees of atherosclerotic disease, from normal coronary arteries (one patient) to three-vessel disease (one patient). During angiography, a transient vasospasm of the left circumflex coronary artery in one patient and the right coronary artery in another occurred spontaneously. In one, the spasm completely occluded the vessel and was accompanied by ST-segment elevation in the inferior leads; in the other (BU), the spasm was not occlusive, markedly delayed distal filling and was accompanied by ST-segment depression in the inferolateral leads. In both patients, the spasm was promptly relieved by intracoronary nitrates. We no longer consider it essential to perform provocative tests in patients with electrocardiographically proved variant angina, particularly when the stress test is negative (three patients) or positive at a rather high work load only (four patients).
